Global Point of Care (PoC) Molecular Diagnostics Market Study 2016-2026, by Segment (Polymerase Chain Reaction (Real Time PCR), In Situ Hybridization, … …), by Market (Hospitals, Diagnostic Laboratories, … …), by Company (Bayer Corporation, R
SKU ID :99ST-14853708 | Published Date: 27-Oct-2019 | No. of pages: 45Description
Summary
The global Point of Care (PoC) Molecular Diagnostics market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Polymerase Chain Reaction (Real Time PCR)
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry
Sequencing
Isothermal Amplification
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Bayer Corporation
Roche Diagnostics
Sysmex Corporation
Abaxis
Abbott Laboratories
BioMerieux SA
Bio-Rad Laboratories
Danaher Corporation
OraSure Technologies
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Point of Care (PoC) Molecular Diagnostics market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Polymerase Chain Reaction (Real Time PCR)
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry
Sequencing
Isothermal Amplification
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Company Coverage (Sales data, Main Products & Services etc.):
Bayer Corporation
Roche Diagnostics
Sysmex Corporation
Abaxis
Abbott Laboratories
BioMerieux SA
Bio-Rad Laboratories
Danaher Corporation
OraSure Technologies
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now